Alendronic acid monohydrate is a bisphosphonate medication mainly used to treat and prevent osteoporosis and Paget’s disease of bone. It works by inhibiting bone resorption, the process by which osteoclasts break down bone tissue. It is grouped under the following drug class(es): Bisphosphonates. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include UNII-78TJA4E8I9 and 78TJA4E8I9. Its PubChem CID is 15585620.
Alendronic acid monohydrate
| CAS No | 138624-11-0 |
|---|---|
| Molecular Formula | C4H15NO8P2 |
| Molecular Weight | 267.11 g/mol |
| Synonyms | 4-amino-1-hydroxy-1-phosphonobutyl)phosphonic acid;hydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Alendronic acid monohydrate is a bisphosphonate medication mainly used to treat and prevent osteoporosis and Paget's disease of bone. It works by inhibiting bone resorption, the process by which osteoclasts break down bone tissue.
The listed CAS number is 138624-11-0.
The listed molecular formula is C4H15NO8P2.
The listed molecular weight is 267.11 g/mol.
4-amino-1-hydroxy-1-phosphonobutyl)phosphonic acid;hydrate.
The source lists UNII-78TJA4E8I9 and 78TJA4E8I9.